APC anti-human CD11b Antibody

Pricing & Availability
Clone
ICRF44 (See other available formats)
Regulatory Status
RUO
Workshop
IV M047
Other Names
Integrin αM chain, C3biR, CR3, Mac-1, Mo1, ITGAM
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
ICRF44_APC_061407
Human peripheral blood granulocytes stained with ICRF44 APC
  • ICRF44_APC_061407
    Human peripheral blood granulocytes stained with ICRF44 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
301309 25 tests £31
Check Availability


Need larger quantities of this item?
Request Bulk Quote
301310 100 tests £91
Check Availability


Need larger quantities of this item?
Request Bulk Quote
301350 100 µg £203
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 165-170 kD type I transmembrane glycoprotein also known as αM integrin, Mac-1, CR3, and C3biR. CD11b non-covalently associates with integrin β2 (CD18) and is expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b/CD18 is critical for the transendothelial migration of monocytes and neutrophils. It is also involved in granulocyte adhesion, phagocytosis, and neutrophil activation. CD11b/CD18 interacts with ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4, CD14, CD23, heparin, iC3b, fibrinogen, and factor X.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
African Green, Baboon, Chimpanzee, Common Marmoset, Pig
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
µg size: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

The ICRF44 antibody inhibits heterotypic adhesion of granulocytes in response to fMLP. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections, immunofluorescence microscopy5, stimulation of monocytes3, blocking of heterotypic PMN aggregation8, and blocking of granulocyte activation12. This clone was tested in-house and does not work on formalin fixed paraffin-embedded (FFPE) tissue.

The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 301361 & 301362).

Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York.
  2. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego.
  3. Rezzonico R, et al. 2001. Blood 97:2932. (Stim)
  4. Marsik C, et al. 2003. Shock 20:493. (FC)
  5. David A, et al. 2003. J. Leukoc. Biol. 74:551. (IF)
  6. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  7. Thurlow LR, et al. 2010. Infect. Immun. 128:1128. (FC) PubMed
  8. Jadhav S, et al. 2001. J. Immunol. 167:5986. (Block)
  9. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  10. Sestak K, et al. 2007. Vet. Immunol. Immunopathol. 119:21. (FC)
  11. Wen T, et al. 2014. J Immunol. 192:5481. (FC) PubMed
  12. Sprong T, et al. 2003. Blood 102:3702. (Block)
  13. Cash JL, et al. 2013. EMBO Rep. 14:999. (FC) PubMed
  14. Larsson K, et al. 2015. PNAS. PubMed
Product Citations
  1. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  2. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  3. Guo X, et al. 2016. Mol Ther Methods Clin Dev. 3:15054. PubMed
  4. Schimek V, et al. 2022. Cell Death Dis. 13:113. PubMed
  5. Richardson SE, et al. 2021. STAR Protocols. 2(2):100420. PubMed
  6. Saggu G, et al. 2018. Nat Commun. 9:5058. PubMed
  7. Schwabenland M, et al. 2021. Acta Neuropathol. 142:923. PubMed
  8. André V, et al. 2012. Blood Cancer J. 2:94. PubMed
  9. Morton JJ, et al. 2018. Mol Carcinog. 57:1651. PubMed
  10. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  11. Hünniger K, et al. 2015. J Immunol. 194:1199. PubMed
  12. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  13. Li Y, et al. 2022. Cell Rep. 38:110284. PubMed
  14. Dan H, et al. 2020. Mol Oncol. 14:795. PubMed
  15. Perelman SS, et al. 2021. Nat Microbiol. 6:731. PubMed
  16. Eriksson E, et al. 2019. J Immunol. 202:787. PubMed
  17. Berger M, et al. 2012. J Biol Chem. 287:19409. PubMed
  18. Szentkereszty M, et al. 2020. Pathol Oncol Res. 26:1117. PubMed
  19. Song M, et al. 2022. J Gene Med. 24:e3455. PubMed
  20. Johnston G, et al. 2020. Gene. 752:144758. PubMed
  21. Velázquez–Avila M, et al. 2019. Leukemia. 33:1337. PubMed
  22. Yang E, et al. 2021. Exp Mol Med. 53:1902. PubMed
  23. Krampert L, et al. 2021. Front Immunol. 12:712948. PubMed
  24. Hazeldine J, et al. 2017. PLoS Med. 10.1371/journal.pmed.1002338. PubMed
  25. Surdziel E, et al. 2017. PLoS One.. 10.1371/journal.pone.0183679. PubMed
  26. Zelter T, et al. 2022. EMBO Rep. 23:e53641. PubMed
  27. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  28. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  29. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  30. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  31. Horn LA, et al. 2017. Oncotarget. 8:57964. PubMed
  32. Collado A, et al. 2021. Front Pharmacol. 12:656244. PubMed
  33. Kiehlmeier S, et al. 2021. Leukemia. Online ahead of prin. PubMed
  34. Konduru NV, et al. 2021. Nanotheranostics. 5:309. PubMed
  35. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  36. Sun Z, et al. 2013. PLoS One. 8:74672. PubMed
  37. Bigley V, et al. 2015. J Leukoc Biol. 97:627. PubMed
  38. Fu Y, et al. 2021. Cell Reports. 36(2):109344. PubMed
  39. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  40. Jardine L, et al. 2019. Nat Commun. 10:1999. PubMed
  41. Sade-Feldman M, et al. 2016. Clin Cancer Res. 22(23):5661-5672. PubMed
  42. Zhai Y, et al. 2018. Autophagy. 1.714583333. PubMed
  43. Thurlow L, et al. 2010. Infect Immun. 78:4936. PubMed
  44. Qiu X, et al. 2022. Cell. 185:690. PubMed
  45. Julian Buchrieser, William James, Michael D. Moore 2017. Stem Cell Reports. 8(2):334-345. PubMed
  46. Wu X, et al. 2022. Front Immunol. 13:849493. PubMed
  47. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
RRID
AB_314161 (BioLegend Cat. No. 301309)
AB_314162 (BioLegend Cat. No. 301310)
AB_2564134 (BioLegend Cat. No. 301350)

Antigen Details

Structure
Integrin, type I transmembrane glycoprotein, associates with integrin β2 (CD18), 165-170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subset of T cells, subset of B cells

Function
Adhesion, phagocytosis, chemotaxis, neutrophil activation
Ligand/Receptor
ICAM-1(CD54), ICAM-2 (CD102), ICAM-4, CD14, CD23, heparin, iC3b, fibrinogen, factor X
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Stewart M, et al. 1995. Curr Opin Cell Biol. 7:690.

Gene ID
3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-human CD11b ICRF44 FC
Biotin anti-human CD11b ICRF44 FC
PE anti-human CD11b ICRF44 FC
PE/Cyanine5 anti-human CD11b ICRF44 FC
Purified anti-human CD11b ICRF44 FC,CyTOF®,ICC,IHC
Pacific Blue™ anti-human CD11b ICRF44 FC
Alexa Fluor® 488 anti-human CD11b ICRF44 FC
Alexa Fluor® 647 anti-human CD11b ICRF44 FC
PE/Cyanine7 anti-human CD11b ICRF44 FC
PerCP/Cyanine5.5 anti-human CD11b ICRF44 FC
Brilliant Violet 421™ anti-human CD11b ICRF44 FC,ICC
Brilliant Violet 570™ anti-human CD11b ICRF44 FC
FITC anti-human CD11b ICRF44 FC
Brilliant Violet 605™ anti-human CD11b ICRF44 FC
Brilliant Violet 510™ anti-human CD11b ICRF44 FC,ICC
Brilliant Violet 650™ anti-human CD11b ICRF44 FC
Purified anti-human CD11b (Maxpar® Ready) ICRF44 FC,CyTOF®
Alexa Fluor® 594 anti-human CD11b ICRF44 ICC,FC
APC/Cyanine7 anti-human CD11b ICRF44 FC
Brilliant Violet 711™ anti-human CD11b ICRF44 FC
Brilliant Violet 785™ anti-human CD11b ICRF44 FC
PE/Dazzle™ 594 anti-human CD11b ICRF44 FC
APC/Fire™ 750 anti-human CD11b ICRF44 FC
APC anti-human CD11b ICRF44 FC
PE anti-human CD11b ICRF44 FC
TotalSeq™-A0161 anti-human CD11b ICRF44 PG
Alexa Fluor® 700 anti-human CD11b ICRF44 FC
PE/Cyanine7 anti-human CD11b ICRF44 FC
TotalSeq™-B0161 anti-human CD11b ICRF44 PG
TotalSeq™-C0161 anti-human CD11b ICRF44 PG
PerCP/Cyanine5.5 anti-human CD11b ICRF44 FC
Ultra-LEAF™ Purified anti-human CD11b ICRF44 FC,CyTOF®,Block,ICC,IHC
TotalSeq™-D0161 anti-human CD11b ICRF44 PG
GMP PE/Cyanine7 anti-human CD11b ICRF44 FC
Pacific Blue™ anti-human CD11b ICRF44 FC
GMP PE anti-human CD11b ICRF44 FC
Spark UV™ 387 anti-human CD11b ICRF44 FC
GMP PerCP/Cyanine5.5 anti-human CD11b ICRF44 FC
FITC anti-human CD11b ICRF44 FC
APC/Fire™ 750 anti-human CD11b ICRF44 FC
GMP APC anti-human CD11b ICRF44 FC
GMP FITC anti-human CD11b ICRF44 FC
GMP APC/Fire™ 750 anti-human CD11b ICRF44 FC
Spark Blue™ 515 anti-human CD11b ICRF44 FC
Spark Violet™ 500 anti-human CD11b ICRF44 FC
Spark Red™ 718 anti-human CD11b (Flexi-Fluor™) ICRF44 FC
Go To Top Version: 4    Revision Date: 07/13/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account